Abstract:The neuroprotective effects of netrin-1 after spinal cord injury and its specific molecular mechanisms have not been elucidated. In our study, Western blot, transferase UTP nick end labeling staining and immunofluorescence staining first showed that netrin-1 significantly decreased the expression levels of caspase-3, caspase-9, transferase UTP nick end labeling-positive neurons, nuclear factor kappa-B, and tumor necrosis factor-alpha after spinal cord injury, which inhibited neuronal apoptosis and inflammatory response. Using Nissl and HE staining, we also found that netrin-1 significantly increased the number of Nissl bodies in the anterior horn of spinal cord and promoted the recovery of injured tissue after spinal cord injury, consequently providing a good microenvironment for recovery of motor function. Finally, the results of Basso, Beattie, and Bresnahan score further confirmed that netrin-1 promoted the recovery of neurological function after spinal cord injury. Furthermore, netrin-1 significantly promoted the expression of beta-catenin and inhibited the expression of glycogen synthase kinase-3 beta, which activated Wnt/beta-catenin signaling pathway after spinal cord injury. However, XAV939 inhibited Wnt/beta-catenin signaling pathway, which significantly inhibited the regulatory effect of netrin-1 on apoptosis, inflammation, Nissl bodies, damaged tissues, and neuroprotection. These results demonstrate for the first time the correlation between netrin-1 and Wnt/beta-catenin signaling pathway after spinal cord injury and show that netrin-1 exerts its neuroprotective effect by activating this signaling pathway after spinal cord injury.

Insights from the neural guidance factor Netrin-1 into neurodegeneration and other diseases

Netrin-1 signaling pathway mechanisms in neurodegenerative diseases

The neuroimmune guidance cue netrin-1: a new therapeutic target in cardiovascular disease.

Research progress of the netrins and their receptors in cancer

Netrin-1 receptor UNC5C cleavage by active -secretase enhances neurodegeneration, promoting Alzheimer's disease pathologies

Neuroprotection of netrin-1 on neurological recovery via Wnt/β-catenin signaling pathway after spinal cord injury.

Expression of Netrin-1 and Its Receptors, Deleted in Colorectal Cancer and Uncoordinated Locomotion-5 Homolog B, in Rat Brain Following Focal Cerebral Ischemia Reperfusion Injury.

Netrin-1 overexpression improves neurobehavioral outcomes and reduces infarct size via inhibition of the notch1 pathway following experimental stroke.

Expression of Netrin-1 and Its Receptors, Deleted in Colorectal Cancer and Uncoordinated Locomotion-5 Homolog B, in Rat Brain Following Focal Cerebralischemia Reperfusion Injury1

Recent progress in studies of neurotrophic factors and their clinical implications

Overexpression of netrin-1 induces neovascularization in the adult mouse brain.

lncRNA NEAT1: key player in neurodegenerative diseases

Development of neurotrophic molecules for treatment of neurodegeneration

A Novel Netrin-1-Derived Peptide Enhances Protection against Neuronal Death and Mitigates of Intracerebral Hemorrhage in Mice

Netrin-1 Overexpression Promotes White Matter Repairing and Remodeling after Focal Cerebral Ischemia in Mice

Neuron-derived Netrin-1 deficiency aggravates spinal cord injury through activating the NF-κB signaling pathway

Netrin-1 controls inflammation in response to ischemic stroke through altering microglia phenotype.

Functions and the Related Signaling Pathways of the Neurotrophic Factor Neuritin

New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders

Overexpression of netrin-1 improves neurological outcomes in mice following transient middle cerebral artery occlusion

BDNF and Its Multirole Function in Neurogenesis, Synaptic Transmission and Neurodegenerative Diseases